Sidewinder Therapeutics
PrivateLast Round
Series B
Apr 8, 2026
Total Funding Raised
$187M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sidewinder Therapeutics is a biopharmaceutical company that develops next-generation bispecific antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sidewinder Therapeutics Comparables
Compare Sidewinder Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neok Bio | 86% | |
| MBrace Therapeutics | 85% | |
| Adcentrx Therapeutics | 82% |
Sidewinder Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 8, 2026 | ||||
| Series A | Oct 25, 2023 |
Key People
Founding team and executive leadership
Sidewinder Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series B |
| Life Sciences at Goldman Sachs Alternatives | Series B |
| OrbiMed | Series B, Series A |
| Frazier Life Sciences | Series B |
| Alexandria Venture Investments | Series B |
| Astellas Venture Management | Series B |
| Goldman Sachs Alternatives | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 52% MoM.
- May 18, 2026
Monthly visitors increased 189% MoM, reaching 3.1K.
Recent news
Latest coverage and updates
- receives_financingSep 14, 2026
Sidewinder Therapeutics, Inc. received financing of $162M in funding on Jul 1st '23.
Sidewinder Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sidewinder Therapeutics's valuation, stock price, and market status.
Is Sidewinder Therapeutics a public or private company?
Sidewinder Therapeutics is a private company.
What is the current stock price of Sidewinder Therapeutics?
Sidewinder Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Sidewinder Therapeutics worth (valuation)?
Valuation information for Sidewinder Therapeutics is not publicly available.
Can I buy Sidewinder Therapeutics stock?
Sidewinder Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sidewinder Therapeutics's last funding round?
Sidewinder Therapeutics's most recent funding round was Series B on April 8, 2026.
Who are the main investors in Sidewinder Therapeutics?
Key investors in Sidewinder Therapeutics include OrbiMed, Frazier Life Sciences.
Will Sidewinder Therapeutics IPO soon?
No public IPO plans have been announced for Sidewinder Therapeutics.
How can I track Sidewinder Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sidewinder Therapeutics's secondary market activity and sign up for updates.